Atossa Therapeutics, Inc. (ATOS): Shareholders' Equity
$39.35M
As of 2025-12-31
$26.83M
As of 2026-06-30
-30.6%
3-year compound annual growth
+7.7%
5-year compound annual growth
+26.5%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $39.35M | -44.9% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $71.48M | -21.5% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $91.02M | -22.8% | 2025-03-25, Balance as of period end |
| 2022-12-31 | $117.96M | -14.6% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $138.14M | +408.5% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $27.17M | +106.5% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $13.16M | +49.4% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $8.81M | +26.9% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $6.94M | +124.0% | 2019-03-28, Balance as of period end |
| 2016-12-31 | $3.10M | -17.2% | 2018-03-08, Balance as of period end |
| 2015-12-31 | $3.74M | -60.6% | 2017-03-21, Balance as of period end |
| 2014-12-31 | $9.50M | -10.4% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $10.60M | +104.8% | 2015-03-30, Balance as of period end |
| 2012-12-31 | $5.18M | +231.8% | 2014-03-27, Balance as of period end |
| 2011-12-31 | $1.56M | n/m | 2014-03-27, Balance as of period end |
| 2010-12-31 | -$851.9K | n/m | 2014-03-27, Balance as of period end |
| 2009-12-31 | $31.7K | n/a | 2014-03-27, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | 2025-12-31 | $39.35M | -44.9% |
| Akari Therapeutics Plc (AKTX) | 2025-12-31 | $28.33M | +27.4% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $24.74M | n/m |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $35.52M | -49.5% |
| Unicycive Therapeutics, Inc. (UNCY) | 2025-12-31 | $30.20M | +306.4% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $40.92M | -32.9% |
| Medicinova Inc (MNOV) | 2025-12-31 | $41.59M | -20.8% |
| Coya Therapeutics, Inc. (COYA) | 2025-12-31 | $43.03M | +8.7% |
| NextCure, Inc. (NXTC) | 2025-12-31 | $34.94M | -46.6% |
Compare ATOS, AKTX, VRCA, VTGN side by side · Screen every company in Pharmaceutical Preparations ↗